Konstantinos Chiotis

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: METHODS IN MOLECULAR BIOLOGY. 2024;2785:195-218

Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach.

Rodriguez-Vieitez E; Kumar A; Malarte M-L; Ioannou K; Rocha FM; Chiotis K
Journal article: ALZHEIMERS & DEMENTIA. 2023;19(S17)

Diagnostic reactive astrogliosis biomarkers in Alzheimer´s disease continuum

Nordberg AK; Chiotis K; Fontana IC; Malarte M; Gillberg P; Bucci M; Bluma M; Kumar A
Journal article: ALZHEIMERS & DEMENTIA. 2023;19(S14)

Associations between Aβ‐PET, CSF pTau, and plasma GFAP, pTau181, pTau231 in memory clinic patients

Bluma M; Bucci M; Ashton NJ; Savitcheva I; Chiotis K; Matton A; Di Molfetta G; Grötschel L; Blennow K; Zetterberg H; Nordberg AK
Article: ALZHEIMERS & DEMENTIA. 2023;19(11):4896-4907

Blood β-synuclein is related to amyloid PET positivity in memory clinic patients.

Oeckl P; Bluma M; Bucci M; Halbgebauer S; Chiotis K; Sandebring-Matton A; Ashton NJ; Molfetta GD; Grötschel L; Kivipelto M; Blennow K; Zetterberg H; Savitcheva I; Nordberg A; Otto M
Article: MOLECULAR NEURODEGENERATION. 2023;18(1):60

Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer's disease with multi-modal PET and plasma GFAP.

Chiotis K; Johansson C; Rodriguez-Vieitez E; Ashton NJ; Blennow K; Zetterberg H; Graff C; Nordberg A
Article: TRANSLATIONAL PSYCHIATRY. 2023;13(1):268

Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinic.

Bucci M; Bluma M; Savitcheva I; Ashton NJ; Chiotis K; Matton A; Kivipelto M; Di Molfetta G; Blennow K; Zetterberg H; Nordberg A
Journal article: ALZHEIMERS & DEMENTIA. 2023;19(S2)

Tracking reactive astrocytes in autosomal dominant Alzheimer disease with plasma GFAP and multi‐modal PET imaging

Chiotis K; Johansson C; Rodriguez‐Vieitez E; Pannee J; Ashton NJ; Blennow K; Zetterberg H; Graff C; Nordberg AK
Journal article: ALZHEIMERS & DEMENTIA. 2023;19(S3)

Reactive astrocytes as imaged with 11C‐DED in patients with different dementia disorders

Chiotis K; Jelic V; Rodriguez‐Vieitez E; Savitcheva I; Wall A; Antoni G; Nordberg AK
Journal article: ALZHEIMERS & DEMENTIA. 2023;19(S2)

High ß‐synuclein plasma levels are coupled with amyloid PET positivity in memory clinic patients

Bluma M; Oeckl P; Bucci M; Halbgebauer S; Chiotis K; Sandebring‐Matton A; Kivipelto M; Savitcheva I; Otto M; Nordberg AK
Journal article: ALZHEIMERS & DEMENTIA. 2022;18(S5)

High tau PET binding reveals a constellation of beta‐amyloid positivity and fast cognitive decline

Ioannou K; Bucci M; Nordberg AK; Chiotis K
Journal article: ALZHEIMERS & DEMENTIA. 2021;17(S5)

Alzheimer’s disease spectrum profiled by CSF and imaging biomarkers: Tau PET best predicts cognitive decline

Bucci M; Chiotis K; Nordberg AK
Article: JOURNAL OF ALZHEIMERS DISEASE. 2021;84(1):103-117

Assessment of Tau Pathology as Measured by 18F-THK5317 and 18F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer's Disease.

Colato E; Chiotis K; Ferreira D; Mazrina MS; Lemoine L; Mohanty R; Westman E; Nordberg A; Rodriguez-Vieitez E; Alzheimer’s Disease Neuroimaging Initiative
Article: MOLECULAR PSYCHIATRY. 2021;26(10):5888-5898

Alzheimer's disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline.

Bucci M; Chiotis K; Nordberg A; Alzheimer’s Disease Neuroimaging Initiative
Article: MOLECULAR PSYCHIATRY. 2021;26(10):5875-5887

[18F]THK5317 imaging as a tool for predicting prospective cognitive decline in Alzheimer's disease.

Chiotis K; Savitcheva I; Poulakis K; Saint-Aubert L; Wall A; Antoni G; Nordberg A
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2021;48(7):2070-2085

The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update.

Boccardi M; Dodich A; Albanese E; Gayet-Ageron A; Festari C; Ashton NJ; Bischof GN; Chiotis K; Leuzy A; Wolters EE; Walter MA; Rabinovici GD; Carrillo M; Drzezga A; Hansson O; Nordberg A; Ossenkoppele R; Villemagne VL; Winblad B; Frisoni GB; Garibotto V
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S5)

Alzheimer’s disease biomarker roadmap 2020: Time for tau

Dodich A; Boccardi M; Ashton NJ; Barthel H; Bischof GN; Carrillo MC; Chiotis K; Corre J; Démonet J; Drzezga A; Gietl AF; Hansson O; Johnson KA; Leuzy A; Lorenzi M; Nordberg AK; Ossenkoppele R; Rabinovici GD; Ratib O; Sabri O; Treyer V; Unschuld PG; Villemagne VLL; Winblad B; Wolters EE; Frisoni GB; Garibotto V
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S5)

Alzheimer’s disease biomarker roadmap 2020: Second‐generation tau PET tracers

Bischof GN; Dodich A; Ashton NJ; Boccardi M; Barthel H; Carrillo MC; Chiotis K; Corre J; Démonet J; Gietl AF; Johnson KA; Hansson O; Leuzy A; Lorenzi M; Nordberg AK; Ossenkoppele R; Rabinovici GD; Ratib O; Sabri O; Treyer V; Unschuld PG; Villemagne VLL; Wolters EE; Winblad B; Frisoni GB; Garibotto V; Drzezga A
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S5)

Alzheimer’s disease biomarker roadmap 2020: Fluid biomarkers

Ashton NJ; Leuzy A; Karikari TK; Dodich A; Boccardi M; Barthel H; Bischof GN; Carrillo MC; Chiotis K; Corre J; Démonet J; Drzezga A; Gietl AF; Johnson KC; Lorenzi M; Nordberg AK; Ossenkoppele R; Rabinovici GD; Ratib O; Sabri O; Treyer V; Unschuld PG; Villemagne VL; Winblad B; Wolters EE; Frisoni GB; Garibotto V; Mattsson N; Zetterberg H; Blennow K; Hansson O
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S5)

Alzheimer’s disease biomarker roadmap 2020: [18F]flortaucipir

Wolters EE; Chiotis K; Dodich A; Ashton NJ; Barthel H; Bischof GN; Boccardi M; Carrillo MC; Corre J; Démonet J; Drzezga A; Gietl AF; Hansson O; Johnson KA; Leuzy A; Lorenzi M; Rabinovici GD; Ratib O; Sabri O; Treyer V; Unschuld PG; Villemagne VLL; Winblad B; Frisoni GB; Garibotto V; Nordberg AK; Ossenkoppele R
Article: BRAIN CONNECTIVITY. 2020;10(10):555-565

Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism.

Smailovic U; Koenig T; Savitcheva I; Chiotis K; Nordberg A; Blennow K; Winblad B; Jelic V
Article: BRAIN COMMUNICATIONS. 2020;2(2):fcaa192

Comparison of subtyping methods for neuroimaging studies in Alzheimer's disease: a call for harmonization.

Mohanty R; Mårtensson G; Poulakis K; Muehlboeck J-S; Rodriguez-Vieitez E; Chiotis K; Grothe MJ; Nordberg A; Ferreira D; Westman E
Journal article: ALZHEIMERS & DEMENTIA. 2019;15(7S_Part_30):p1554

P4‐599: ANTE‐MORTEM BINDING OF 18F‐THK5317 PET IN A CASE OF FTLD AND POST‐MORTEM COMPARISON OF TAU BINDING USING 3H‐THK5117 AND 3H‐MK6240

Lemoine L; Chiotis K; Leuzy A; Nennesmo I; Nordberg AK
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2019;46(6):1369-1382

Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging.

Murugan NA; Chiotis K; Rodriguez-Vieitez E; Lemoine L; Ågren H; Nordberg A
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2019;46(6):1276-1286

Clinical impact of [18F]flutemetamol PET among memory clinic patients with an unclear diagnosis.

Leuzy A; Savitcheva I; Chiotis K; Lilja J; Andersen P; Bogdanovic N; Jelic V; Nordberg A
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2019;46(5):1152-1163

Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease.

Leuzy A; Cicognola C; Chiotis K; Saint-Aubert L; Lemoine L; Andreasen N; Zetterberg H; Ye K; Blennow K; Höglund K; Nordberg A
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2019;46(2):348-356

Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer's disease.

Carter SF; Chiotis K; Nordberg A; Rodriguez-Vieitez E
Article: JOURNAL OF NUCLEAR MEDICINE. 2019;60(2):285-291

Spatial Normalization of 18F-Flutemetamol PET Images Using an Adaptive Principal-Component Template.

Lilja J; Leuzy A; Chiotis K; Savitcheva I; Sörensen J; Nordberg A
Article: NEUROIMAGE-CLINICAL. 2019;22:101681

Optimal timing of tau pathology imaging and automatic extraction of a reference region using dynamic [18F]THK5317 PET.

Jonasson M; Wall A; Chiotis K; Leuzy A; Eriksson J; Antoni G; Nordberg A; Lubberink M
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2018;45(9):1605-1617

Dual tracer tau PET imaging reveals different molecular targets for 11C-THK5351 and 11C-PBB3 in the Alzheimer brain.

Chiotis K; Stenkrona P; Almkvist O; Stepanov V; Ferreira D; Arakawa R; Takano A; Westman E; Varrone A; Okamura N; Shimada H; Higuchi M; Halldin C; Nordberg A
Journal article: ALZHEIMERS & DEMENTIA. 2018;14(7S_Part_30):p1573-p1574

P4‐308: MODELLING THE ASSOCIATIONS BETWEEN [18F]AV1451, [18F]FDG PET AND COGNITION IN MILD COGNITIVE IMPAIRMENT AND AD DEMENTIA

Mazrina MS; Chiotis K; Colato E; Nordberg AK; Rodriguez-Vieitez E; Initiative ADN
Journal article: ALZHEIMERS & DEMENTIA. 2018;14(7S_Part_1):p22

IC‐P‐016: ESTIMATION OF AMYLOID LOAD USING [18F]FLUTEMETAMOL AND A NORMALIZATION DERIVED WEIGHTING FACTOR: POTENTIAL APPLICATIONS IN AMYLOID PET

Leuzy A; Lilja J; Heurling K; Chiotis K; Savitcheva I; Nordberg AK
Journal article: ALZHEIMERS & DEMENTIA. 2018;14(7S_Part_9):p504-p505

P1‐473: ESTIMATION OF AMYLOID LOAD USING [18F]FLUTEMETAMOL AND A NORMALIZATION‐DERIVED WEIGHTING FACTOR: POTENTIAL APPLICATIONS IN AMYLOID PET

Leuzy A; Lilja J; Heurling K; Chiotis K; Savitcheva I; Nordberg AK
Article: MOLECULAR PSYCHIATRY. 2018;23(7):1666-1673

Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.

Chiotis K; Saint-Aubert L; Rodriguez-Vieitez E; Leuzy A; Almkvist O; Savitcheva I; Jonasson M; Lubberink M; Wall A; Antoni G; Nordberg A
Article: ALZHEIMERS & DEMENTIA. 2018;14(5):652-663

Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease.

Leuzy A; Rodriguez-Vieitez E; Saint-Aubert L; Chiotis K; Almkvist O; Savitcheva I; Jonasson M; Lubberink M; Wall A; Antoni G; Nordberg A
Article: ALZHEIMER'S AND DEMENTIA: DIAGNOSIS, ASSESSMENT AND DISEASE MONITORING. 2018;10:232-236

Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target binding.

Lemoine L; Leuzy A; Chiotis K; Rodriguez-Vieitez E; Nordberg A
Article: NEUROIMAGE-CLINICAL. 2018;20:603-610

Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species.

Oliveira F; Leuzy A; Castelhano J; Chiotis K; Hasselbalch SG; Rinne J; Mendonça A; Otto M; Lleó A; Santana I; Johansson J; Anderl-Straub S; Arnim C; Beer A; Blesa R; Fortea J; Sanna-Kaisa H; Portelius E; Pannee J; Zetterberg H; Blennow K; Moreira AP; Abrunhosa A; Nordberg A; Castelo-Branco M
Article: JOURNAL OF ALZHEIMERS DISEASE. 2017;59(2):603-614

A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.

Iaccarino L; Chiotis K; Alongi P; Almkvist O; Wall A; Cerami C; Bettinardi V; Gianolli L; Nordberg A; Perani D
Journal article: ALZHEIMERS & DEMENTIA. 2017;13(7S_Part_15):p765

[P2–366]: HEAD‐TO‐HEAD IN VIVO COMPARISON OF TAU‐SPECIFIC PET TRACERS IN ALZHEIMER's DISEASE: [11C]THK5351 VERSUS [11C]PBB3 PET IMAGING

Chiotis K; Stenkrona P; Almkvist O; Arakawa R; Takano A; Stepanov V; Varrone A; Higuchi M; Halldin C; Nordberg A
Journal article: ALZHEIMERS & DEMENTIA. 2017;13(7S_Part_2):p133

[IC‐P‐178]: HEAD‐TO‐HEAD IN VIVO COMPARISON OF TAU‐SPECIFIC PET TRACERS IN ALZHEIMER's DISEASE: [11C]THK5351 VERSUS [11C]PBB3 PET IMAGING

Chiotis K; Stenkrona P; Almkvist O; Arakawa R; Takano A; Stepanov V; Varrone A; Higuchi M; Halldin C; Nordberg A
Journal article: ALZHEIMERS & DEMENTIA. 2017;13(7S_Part_8):p394-p395

[P1–357]: INVESTIGATING THE CLINICAL IMPACT OF [18F]FLUTEMETAMOL PET IN A TERTIARY MEMORY CLINIC SETTING IN PATIENTS WITH UNCERTAIN DIAGNOSIS

Leuzy A; Chiotis K; Jelic V; Andersen P; Friman J; Lilja J; Savitcheva I; Nordberg A
Journal article: ALZHEIMERS & DEMENTIA. 2017;13(7S_Part_1):p19-p20

[IC‐P‐016]: INVESTIGATING THE CLINICAL IMPACT OF [18F]FLUTEMETAMOL PET IN A TERTIARY MEMORY CLINIC SETTING IN PATIENTS WITH UNCERTAIN DIAGNOSIS

Leuzy A; Chiotis K; Jelic V; Andersen P; Friman J; Lilja J; Savitcheva I; Nordberg A
Article: NEUROBIOLOGY OF AGING. 2017;52:214-227

Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.

Chiotis K; Saint-Aubert L; Boccardi M; Gietl A; Picco A; Varrone A; Garibotto V; Herholz K; Nobili F; Nordberg A; Geneva Task Force for the Roadmap of Alzheimer's B
Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2017;37(2):740-749

Comparability of [18F]THK5317 and [11C]PIB blood flow proxy images with [18F]FDG positron emission tomography in Alzheimer's disease.

Rodriguez-Vieitez E; Leuzy A; Chiotis K; Saint-Aubert L; Wall A; Nordberg A
Article: ALZHEIMERS RESEARCH & THERAPY. 2016;8(1):38

Regional tau deposition measured by [18F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer's disease.

Saint-Aubert L; Almkvist O; Chiotis K; Almeida R; Wall A; Nordberg A
Article: BRAIN. 2016;139(Pt 9):2540-2553

Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study.

Leuzy A; Chiotis K; Hasselbalch SG; Rinne JO; de Mendonça A; Otto M; Lleó A; Castelo-Branco M; Santana I; Johansson J; Anderl-Straub S; von Arnim CAF; Beer A; Blesa R; Fortea J; Herukka S-K; Portelius E; Pannee J; Zetterberg H; Blennow K; Nordberg A
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2016;43(9):1686-1699

Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm.

Chiotis K; Saint-Aubert L; Savitcheva I; Jelic V; Andersen P; Jonasson M; Eriksson J; Lubberink M; Almkvist O; Wall A; Antoni G; Nordberg A
Article: JOURNAL OF NUCLEAR MEDICINE. 2016;57(7):1071-1077

Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease.

Rodriguez-Vieitez E; Carter SF; Chiotis K; Saint-Aubert L; Leuzy A; Schöll M; Almkvist O; Wall A; Långström B; Nordberg A
Journal article: ALZHEIMERS & DEMENTIA. 2016;12(7S_Part_24):p1171

P4‐349: EARLY‐PHASE [11C]PIB PET is Comparable to [18F]FDG PET as a Marker of Disease Progression in Alzheimer's Disease

Rodriguez-Vieitez E; Leuzy A; Chiotis K; Saint-Aubert L; Almkvist O; Wall A; Nordberg A
Journal article: ALZHEIMERS & DEMENTIA. 2016;12(7S_Part_7):p348-p349

O4‐07‐03: Longitudinal Changes in Regional Tau Deposition in Alzheimer's Disease and other Tauopathies Measured by [18F]‐TKH5317 Pet in a Multi‐Tracer Design

Nordberg A; Chiotis K; Saint-Aubert L; Savitcheva I; Jelic V; Andersen P; Almkvist O; Wall A; Antoni G
Journal article: ALZHEIMERS & DEMENTIA. 2016;12(7S_Part_19):p932-p933

P3‐262: TAU PET Imaging in Non‐Alzheimer’S Disease Dementia: a Multimodal Paradigm

Chiotis K; Saint-Aubert L; Savitcheva I; Jelic V; Wall A; Antoni G; Nordberg A
Journal article: ALZHEIMERS & DEMENTIA. 2016;12(7S_Part_3):p137

IC‐P‐189: TAU PET Imaging in Non‐Alzheimer’S Disease Dementia: A Multimodal Paradigm

Chiotis K; Saint-Aubert L; Savitcheva I; Jelic V; Wall A; Antoni G; Nordberg A
Journal article: ALZHEIMERS & DEMENTIA. 2016;12(7S_Part_11):p539-p540

P1‐306: Association Between in Vivo TAU Deposition Measured Using [18F]THK5317 Pet and Cognitive Functions in Alzheimer's Disease

Saint-Aubert L; Chiotis K; Wall A; Almkvist O; Nordberg A
Journal article: ALZHEIMERS & DEMENTIA. 2016;12(7S_Part_14):p679-p680

P2‐167: Roadmap to the Biomarker‐Based Diagnosis of Alzheimer's Disease

Boccardi M; Yasui Y; Cerami C; Chiotis K; Garibotto V; Mattsson N; Sonni I; Kate MT; Porteri C; Jack CR; Winblad B; Frisoni GB; Biomarkers GTFFTRO
Journal article: ALZHEIMERS & DEMENTIA. 2016;12(7S_Part_1):p13

IC‐P‐002: : Roadmap to The Biomarker‐Based Diagnosis of Alzheimer’s Disease

Boccardi M; Yasui Y; Cerami C; Chiotis K; Garibotto V; Mattsson N; Sonni I; Kate MT; Porteri C; Jack CR; Winblad B; Frisoni GB; Biomarkers GTFFTRO
Article: JOURNAL OF NUCLEAR MEDICINE. 2016;57(4):574-581

Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.

Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M
Article: BRAIN. 2016;139(Pt 3):922-936

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.

Rodriguez-Vieitez E; Saint-Aubert L; Carter SF; Almkvist O; Farid K; Schöll M; Chiotis K; Thordardottir S; Graff C; Wall A; Långström B; Nordberg A
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2015;42(10):1492-1506

Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging.

Chiotis K; Carter SF; Farid K; Savitcheva I; Nordberg A; Diagnostic Molecular Imaging (DiMI) network and th
Journal article: ALZHEIMERS & DEMENTIA. 2015;11(7S_Part_3):p127

O1‐02‐03: Divergent pattern of changes in astrocytosis and fibrillar amyloid plaques as measured by PET in autosomal‐dominant and sporadic Alzheimer's disease

Rodriguez-Vieitez E; Carter SF; Saint-Aubert L; Almkvist O; Farid K; Schöll M; Chiotis K; Thordardottir S; Wall A; Graff C; Långström B; Nordberg A
Journal article: ALZHEIMERS & DEMENTIA. 2015;11(7S_Part_2):p86

IC‐P‐126: Divergent pattern of changes in astrocytosis and fibrillar amyloid plaques as measured by PET in autosomal‐dominant and sporadic Alzheimer's disease

Rodriguez-Vieitez E; Carter SF; Saint-Aubert L; Almkvist O; Farid K; Schöll M; Chiotis K; Thordardottir S; Wall A; Graff C; Långström B; Nordberg A
Article: JOURNAL OF ALZHEIMERS DISEASE. 2015;45(4):1077-1088

Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease.

Leuzy A; Carter SF; Chiotis K; Almkvist O; Wall A; Nordberg A
Journal article: NEUROLOGY. 2015;84(14_supplement)

A multi-center cross-validation of FDG- and amyloid-PET as in vivo biomarkers for the prediction of MCI progression (P4.086)

Iaccarino L; Chiotis K; Alongi P; Cerami C; Marcone A; Bettinardi V; Iannaccone S; Cappa S; Nordberg A; Perani D
Journal article: ALZHEIMERS & DEMENTIA. 2014;10(4S_Part_6):p18

IC‐P‐025: AGE IS A SIGNIFICANT FACTOR IN DETERMINING PATHOLOGICAL POSITIVITY MEASURED WITH [18F]FLORBETAPIR PET

Chiotis K; Carter SF; Farid K; Nordberg A
Journal article: ALZHEIMERS & DEMENTIA. 2014;10(4S_Part_19):p710-p711

P3‐218: AGE IS A SIGNIFICANT FACTOR IN DETERMINING PATHOLOGICAL POSITIVITY MEASURED WITH [18F]FLORBETAPIR PET

Chiotis K; Carter SF; Farid K; Nordberg A
Journal article: CLINICAL NEUROPHYSIOLOGY. 2014;125:s104-s105

P213: Bifid median nerve is not associated with carpal tunnel syndrome or hand/wrist configuration

Chiotis K; Dimisianos N; Rigopoulou A; Chrysanthopoulou A; Chroni E
Journal article: ALZHEIMERS & DEMENTIA. 2013;9(4S_Part_1):p13

IC‐P‐006: Comparison of PiB‐PET data to florbetapir‐PET data acquired from different patient cohorts at different research sites

Chiotis K; Carter S; Nordberg A
Journal article: ALZHEIMERS & DEMENTIA. 2013;9(4S_Part_7):p275

P1–320: Comparison of PiB‐PET data to florbetapir‐PET data acquired from cohorts at different research sites

Chiotis K; Carter S; Nordberg A
Visa fler

Alla övriga publikationer

Review: CELLS. 2023;12(11):1469

Astrocyte Signature in Alzheimer's Disease Continuum through a Multi-PET Tracer Imaging Perspective.

Fontana IC; Scarpa M; Malarte M-L; Rocha FM; Ausellé-Bosch S; Bluma M; Bucci M; Chiotis K; Kumar A; Nordberg A
Corrigendum: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2021;48(13):4525-4531

Correction to: The Strategic Biomarker Roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update.

Boccardi M; Dodich A; Albanese E; Gayet-Ageron A; Festari C; Ashton NJ; Bischof GN; Chiotis K; Leuzy A; Wolters EE; Walter M; Rabinovici GD; Carrillo M; Drzezga A; Hansson O; Nordberg A; Ossenkoppele R; Villemagne VL; Winblad B; Frisoni G; Garibotto V
Review: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2021;48(7):2086-2096

Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.

Chiotis K; Dodich A; Boccardi M; Festari C; Drzezga A; Hansson O; Ossenkoppele R; Frisoni G; Garibotto V; Nordberg A
Preprint: MEDRXIV. 2020

Towards harmonizing subtyping methods for neuroimaging studies in Alzheimer’s disease

Mohanty R; Mårtensson G; Poulakis K; Muehlboeck J-S; Rodriguez-Vieitez E; Chiotis K; Grothe M; Nordberg A; Ferreira D; Westman E
Review: MOLECULAR PSYCHIATRY. 2019;24(8):1112-1134

Tau PET imaging in neurodegenerative tauopathies-still a challenge.

Leuzy A; Chiotis K; Lemoine L; Gillberg P-G; Almkvist O; Rodriguez-Vieitez E; Nordberg A
Thesis / dissertation: 2017

Molecular imaging of tau in the pathological cascade of Alzheimer’s disease

Chiotis, Konstantinos
Review: LANCET NEUROLOGY. 2017;16(8):661-676

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers.

Frisoni GB; Boccardi M; Barkhof F; Blennow K; Cappa S; Chiotis K; Démonet J-F; Garibotto V; Giannakopoulos P; Gietl A; Hansson O; Herholz K; Jack CR; Nobili F; Nordberg A; Snyder HM; Ten Kate M; Varrone A; Albanese E; Becker S; Bossuyt P; Carrillo MC; Cerami C; Dubois B; Gallo V; Giacobini E; Gold G; Hurst S; Lönneborg A; Lovblad K-O; Mattsson N; Molinuevo J-L; Monsch AU; Mosimann U; Padovani A; Picco A; Porteri C; Ratib O; Saint-Aubert L; Scerri C; Scheltens P; Schott JM; Sonni I; Teipel S; Vineis P; Visser PJ; Yasui Y; Winblad B
Review: MOLECULAR NEURODEGENERATION. 2017;12(1):19

Tau PET imaging: present and future directions.

Saint-Aubert L; Lemoine L; Chiotis K; Leuzy A; Rodriguez-Vieitez E; Nordberg A
Conference publication: JOURNAL OF NUCLEAR MEDICINE. 2017;58

Spatial normalization of [¹⁸F] flutemetamol PET images utilizing an adaptive principal components template

Lilja J; Leuzy A; Chiotis K; Savitcheva I; Sorensen J; Nordberg A
Meeting abstract: NEUROBIOLOGY OF AGING. 2016;39:S18

IMPROVED CONCORDANCE BETWEEN [11C]PIB PET AND CSF Aβ42 USING Aβ42/Aβ40: FINDINGS FROM A MULTICENTRE EUROPEAN MEMORY CLINIC POPULATION

Leuzy A; Chiotis K; Pannee J; Hasselbalch S; Rinne J; Castelo-Branco M; Mendonca A; Santana I; Bisa AL; Johansson J; Otto M; Portelius E; Zetterberg H; Blennow K; Nordberg A
Meeting abstract: NEUROBIOLOGY OF AGING. 2016;39:s29

TAU PET IMAGING IN NEURODEGENERATIVE TAUOPATHIES - A MULTIMODAL PARADIGM

Chiotis K; Saint-Aubert L; Leuzy A; Rodriguez-Vieitez E; Nordberg A
Meeting abstract: NEUROBIOLOGY OF AGING. 2016;39:s21

COMPARISON OF EARLY-PHASE (S)-[18F]THK5117 AND [11C]PIB PET IMAGING TO ASSESS BRAIN PERFUSION IN ALZHEIMER'S DISEASE

Rodriguez-Vieitez E; Leuzy A; Chiotis K; Saint-Aubert L; Nordberg A
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2016;36:16-17

TRACER KINETIC ANALYSIS OF [18F](S)-THK5117 AS A PET TRACER FOR TAU PATHOLOGY

Lubberink M; Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Eriksson J; Sorensen J; Okamura N; Antoni G; Nordberg A
Conference publication: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2016;43:S25

Supervised Cluster Analysis for Automatic Extraction of Reference Region in Dynamic [¹⁸F]THK5317 PET

Jonasson M; Wall A; Chiotis K; Heurling K; Saint-Aubert L; Antoni G; Nordberg A; Lubberink M
Conference publication: JOURNAL OF NUCLEAR MEDICINE. 2015;56(3)

Tracer kinetic analysis of (S)-[¹⁸F]THK5117 as a PET tracer for tau pathology

Lubberink M; Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Eriksson J; Sorensen J; Okamura N; Antoni G; Nordberg A
Published conference paper: ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION. 2013;94(4):737-744

Role of anthropometric characteristics in idiopathic carpal tunnel syndrome.

Chiotis K; Dimisianos N; Rigopoulou A; Chrysanthopoulou A; Chroni E
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2012;19:778

Idiopathic carpal tunnel syndrome: is it really idiopathic? The role of anthropometric hand measurements

Chiotis K; Dimisianos N; Rigopoulou A; Chrysanthopoulou A; Chroni E

Examina och utbildning

Medicine Doktorsexamen, Institutionen för neurobiologi, vårdvetenskap och samhälle, Karolinska Institutet, 2018

Artiklar

Alla övriga publikationer

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI